EOLS
Evolus Inc
Price:  
12.04 
USD
Volume:  
419,593.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-275.0%
Upside

As of 2024-12-11, the Relative Valuation of Evolus Inc (EOLS) is (21.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.04 USD, the upside of Evolus Inc based on Relative Valuation is -275.0%.

The range of the Relative Valuation is (13.28) - (21.14) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 15.1x - 24.1x 22.7x
Forward P/E multiples 15.2x - 25.7x 25.4x
Fair Price (13.28) - (21.14) (21.06)
Upside -210.3% - -275.6% -275.0%
12.04 USD
Stock Price
(21.06) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2024-12-06 -14.45
2024-12-05 -14.49
2024-12-04 -14.80
2024-12-03 -14.96
2024-12-02 -15.42
2024-11-29 -15.63
2024-11-27 -15.76
2024-11-26 -14.65
2024-11-25 -14.47
2024-11-22 -14.39
2024-11-21 -14.89
2024-11-20 -14.42
2024-11-19 -14.15
2024-11-18 -13.69
2024-11-15 -13.83
2024-11-14 -13.56
2024-11-13 -13.99
2024-11-12 -14.20
2024-11-11 -14.98
2024-11-08 -15.62
2024-11-07 -16.32
2024-11-06 -19.19
2024-11-05 -18.83
2024-11-04 -18.75
2024-11-01 -19.12
2024-10-31 -18.63
2024-10-30 -19.12
2024-10-29 -19.06
2024-10-28 -18.58
2024-10-25 -18.79
2024-10-24 -18.03
2024-10-23 -17.85
2024-10-22 -18.31
2024-10-21 -18.54
2024-10-18 -18.98
2024-10-17 -18.99
2024-10-16 -19.92
2024-10-15 -19.07
2024-10-14 -19.68
2024-10-11 -19.30
2024-10-10 -18.90
2024-10-09 -19.15
2024-10-08 -18.84
2024-10-07 -18.83
2024-10-04 -18.66
2024-10-03 -19.47
2024-10-02 -19.57
2024-10-01 -19.43
2024-09-30 -18.50
2024-09-27 -18.21